Immunodeficiencies

D3_IMMUDEF

No definition available.

Similar endpoints

List of similar endpoints to Immunodeficiencies based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 1065 679 386
Unadjusted prevalence (%) 0.35 0.39 0.29
Mean age at first event (years) 48.09 46.85 50.25

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.22 [1.07, 4.59] 3.2e-2 108
15 years 0.01 1.13 [0.58, 2.21] 7.2e-1 40
5 years 0.00 3.25 [1.70, 6.20] 3.6e-4 29
1 year 0.00 14.63 [7.72, 27.71] 1.9e-16 24

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: D3_IMMUDEF – Immunodeficiencies
GWS hits: 0

Survival analyses between endpoints

Plot

before Immunodeficiencies
after Immunodeficiencies

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Immunodeficiencies